Evaluation of efficacy and safety of Polyherbal Unani formulations in the management of Eczema
- Conditions
- Health Condition 1: L20-L30- Dermatitis and eczema
- Registration Number
- CTRI/2024/02/062979
- Lead Sponsor
- Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients who are willing and able to comply with the scheduled visits and treatment plan, laboratory testing and other study procedure and capable of providing a signed informed consent form indicating the subject has been informed of all pertinent aspects of the study.
1.Patients with an evidence of clinically significant and uncontrolled systemic illness.
2.Patients with a current diagnosis of active skin disease (e.g., psoriasis, lupus erythematosus) or skin infection (bacterial, fungal or viral) especially in place of eczema at the same time.
3. Patients who had been using topical steroids within past 14 days.
4. Pregnant and lactating women.
5. Patients who have a known history or clinically relevant allergy, in particular to any component of the study treatment.
6. Patients unlikely to cooperate with the study protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.POEM (Patient Oriented Eczema Measure) <br/ ><br>2. EASI (Eczema Area and Severity Index) Score <br/ ><br>3. Pruritus NRS AssessmentTimepoint: Baseline, 2nd week ,4th week and 6th week
- Secondary Outcome Measures
Name Time Method DLQI ( Dermatology Life Quality IndexTimepoint: Baseline & 6th week